185 related articles for article (PubMed ID: 27851688)
1. Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies.
Tippin TK; Morrison ME; Brundage TM; Momméja-Marin H
Ther Drug Monit; 2016 Dec; 38(6):777-786. PubMed ID: 27851688
[TBL] [Abstract][Full Text] [Related]
2. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections.
Alvarez-Cardona JJ; Whited LK; Chemaly RF
Future Microbiol; 2020 Apr; 15():389-400. PubMed ID: 32166967
[TBL] [Abstract][Full Text] [Related]
3. A quantitative LC-MS/MS method for the determination of tissue brincidofovir and cidofovir diphosphate in a MuPyV-infected mouse model.
Guzman BB; Schauer AP; Dunn JA; Cottrell ML; Sykes C
Biomed Chromatogr; 2021 May; 35(5):e5061. PubMed ID: 33398885
[TBL] [Abstract][Full Text] [Related]
4. A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity.
Nieskens TT; Peters JG; Schreurs MJ; Smits N; Woestenenk R; Jansen K; van der Made TK; Röring M; Hilgendorf C; Wilmer MJ; Masereeuw R
AAPS J; 2016 Mar; 18(2):465-75. PubMed ID: 26821801
[TBL] [Abstract][Full Text] [Related]
5. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
Grimley MS; Chemaly RF; Englund JA; Kurtzberg J; Chittick G; Brundage TM; Bae A; Morrison ME; Prasad VK
Biol Blood Marrow Transplant; 2017 Mar; 23(3):512-521. PubMed ID: 28063938
[TBL] [Abstract][Full Text] [Related]
6. First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses.
Painter W; Robertson A; Trost LC; Godkin S; Lampert B; Painter G
Antimicrob Agents Chemother; 2012 May; 56(5):2726-34. PubMed ID: 22391537
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of brincidofovir on parvovirus B19.
Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
[TBL] [Abstract][Full Text] [Related]
9. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.
Cihlar T; Ho ES; Lin DC; Mulato AS
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):641-8. PubMed ID: 11563082
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease.
Trost LC; Rose ML; Khouri J; Keilholz L; Long J; Godin SJ; Foster SA
Antiviral Res; 2015 May; 117():115-21. PubMed ID: 25746331
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.
Ho ES; Lin DC; Mendel DB; Cihlar T
J Am Soc Nephrol; 2000 Mar; 11(3):383-393. PubMed ID: 10703662
[TBL] [Abstract][Full Text] [Related]
12. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
Cesaro S; Zhou X; Manzardo C; Buonfrate D; Cusinato R; Tridello G; Mengoli C; Palù G; Messina C
J Clin Virol; 2005 Oct; 34(2):129-32. PubMed ID: 16157264
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
Chamberlain JM; Sortino K; Sethna P; Bae A; Lanier R; Bambara RA; Dewhurst S
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397065
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule.
Miller DS
J Pharmacol Exp Ther; 2001 Nov; 299(2):567-74. PubMed ID: 11602668
[TBL] [Abstract][Full Text] [Related]
15. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
[TBL] [Abstract][Full Text] [Related]
16. The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus.
McMullan LK; Flint M; Dyall J; Albariño C; Olinger GG; Foster S; Sethna P; Hensley LE; Nichol ST; Lanier ER; Spiropoulou CF
Antiviral Res; 2016 Jan; 125():71-8. PubMed ID: 26526586
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir.
Hanaoka N; Hazama M; Fukushima K; Fujimoto T
Microbiol Spectr; 2022 Feb; 10(1):e0156921. PubMed ID: 35171015
[TBL] [Abstract][Full Text] [Related]
18. Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity.
Bam RA; Yant SR; Cihlar T
Antivir Ther; 2014; 19(7):687-92. PubMed ID: 24699134
[TBL] [Abstract][Full Text] [Related]
19. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
Yaro P; Nie J; Xu M; Zeng K; He H; Yao J; Wang R; Zeng S
J Ethnopharmacol; 2019 Oct; 243():112098. PubMed ID: 31325605
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.
Aitken SL; Zhou J; Ghantoji SS; Kontoyiannis DP; Jones RB; Tam VH; Chemaly RF
J Antimicrob Chemother; 2016 Mar; 71(3):727-30. PubMed ID: 26612873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
